Tech Company Inital Public Offerings

Enumeral Biomedical IPO

On 8/4/2014, Enumeral Biomedical went public.

Transaction Overview

Announced On
8/4/2014
Transaction Type
IPO
Amount
$21,500,000
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Cambridge Park Dr.
Cambridge, MA 02140
USA
Email Address
Overview
Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.
Profile
Enumeral Biomedical LinkedIn Company Profile
Social Media
Enumeral Biomedical Company Twitter Account
Company News
Enumeral Biomedical News
Facebook
Enumeral Biomedical on Facebook
YouTube
Enumeral Biomedical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Sarney
  Kevin Sarney LinkedIn Profile  Kevin Sarney Twitter Account  Kevin Sarney News  Kevin Sarney on Facebook
VP - General Counsel
Matthew Ebert
  Matthew Ebert LinkedIn Profile  Matthew Ebert Twitter Account  Matthew Ebert News  Matthew Ebert on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/4/2014: Profectus BioSciences venture capital transaction
Next: 8/4/2014: Adama Materials venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary